Health Catalyst, Inc. $HCAT Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. reduced its investment in Health Catalyst by 6.0%, selling 263,078 shares, and now holds 4,131,653 shares valued at approximately $18.7 million.
• Health Catalyst has recently faced multiple downgrades from various analysts, with Citigroup lowering its rating from "buy" to "neutral" and cutting the price target from $6.50 to $3.50.
• The company's stock is currently trading at $3.39, with analysts issuing a consensus rating of "Hold" and a target price of $5.42.

Vanguard Group Inc. cut its holdings in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 6.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,131,653 shares of the company's stock after selling 263,078 shares during the period. Vanguard Group Inc. owned about 5.88% of Health Catalyst worth $18,716,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Wells Fargo & Company MN increased its holdings in Health Catalyst by 27.3% during the 4th quarter. Wells Fargo & Company MN now owns 39,355 shares of the company's stock worth $278,000 after purchasing an additional 8,451 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of Health Catalyst by 92.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 33,773 shares of the company's stock worth $239,000 after buying an additional 16,208 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Health Catalyst by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,591,565 shares of the company's stock worth $11,252,000 after buying an additional 235,686 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Health Catalyst by 8.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 62,443 shares of the company's stock valued at $442,000 after acquiring an additional 4,798 shares in the last quarter. Finally, Two Sigma Securities LLC boosted its stake in Health Catalyst by 19.5% during the 4th quarter. Two Sigma Securities LLC now owns 17,510 shares of the company's stock valued at $124,000 after acquiring an additional 2,862 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HCAT shares. Wells Fargo & Company dropped their target price on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a research report on Monday, August 11th. Evercore ISI boosted their price objective on Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a report on Thursday, August 28th. Summit Redstone set a $5.00 target price on Health Catalyst in a report on Friday, August 29th. Stifel Nicolaus decreased their target price on Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a research report on Friday, August 8th. Finally, Piper Sandler lowered Health Catalyst from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $8.00 to $4.00 in a research report on Wednesday, August 27th. Three research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $4.73.

Health Catalyst Stock Performance

Health Catalyst stock traded up $0.06 during midday trading on Thursday, reaching $3.30. 874,650 shares of the stock traded hands, compared to its average volume of 1,140,632. Health Catalyst, Inc. has a fifty-two week low of $2.52 and a fifty-two week high of $9.24. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. The firm has a market cap of $232.22 million, a price-to-earnings ratio of -2.19 and a beta of 1.53. The firm has a fifty day moving average price of $3.59 and a two-hundred day moving average price of $3.95.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.